Developing Scalable Screening Technologies to Accelerate LNP Design from Bench to Bedside

• Explore high-throughput screening innovations that streamline the identification of optimal LNP formulations
• Learn how scalable platforms enable efficient transition from discovery to clinical-grade manufacturing
• Understand how technology transfer strategies are bridging preclinical development with clinical translation

Speakers:

Regina Bleul

Head of nanomedicine group

Fraunhofer ICT-IMM